cgp 6809 has been researched along with Neoplasms in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fiebig, HH; Löhr, GW; Widmer, KH; Winterhalter, BR | 1 |
Cowens, JW; Creaven, PJ; Huben, R; Karakousis, C; Petrelli, N; Traynor, D | 1 |
Cowens, JW; Creaven, PJ; Huben, R; Karakousis, C; Madajewicz, S; Mittelman, A; Pendyala, L; Petrelli, N; Plager, JE; Takita, H | 1 |
1 trial(s) available for cgp 6809 and Neoplasms
Article | Year |
---|---|
Phase I clinical trial of ethyl 6-deoxy-3,5-di-O-methyl 6-(3 methyl-3-nitrosoureido)-alpha-D-glucofuranoside (CGP 6809).
Topics: Adult; Aged; Chromatography, High Pressure Liquid; Clinical Trials as Topic; Female; Humans; Infusions, Intravenous; Kinetics; Liver Function Tests; Male; Middle Aged; Nausea; Neoplasms; Nitrosourea Compounds; Vomiting | 1987 |
2 other study(ies) available for cgp 6809 and Neoplasms
Article | Year |
---|---|
CGP 6809--a new nitrosoureido-sugar derivative with activity in human tumor xenografts.
Topics: Animals; Antineoplastic Agents; Drug Evaluation, Preclinical; Female; Humans; Mice; Mice, Nude; Neoplasm Transplantation; Neoplasms; Nitrosourea Compounds; Transplantation, Heterologous | 1989 |
Phase I trial of a new nitrosourea, CGP 6809, given every 2 weeks.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Drug Evaluation; Drug Tolerance; Female; Humans; Male; Middle Aged; Neoplasms; Nitrosourea Compounds; Time Factors | 1989 |